Two doses of AstraZeneca’s COVID-19 vaccine results in 89 percent. Effective in preventing the symptomatic course of this disease, the preparation company Pfizer and BioNTech contains 90%. Efficacy according to vaccination studies published in England on Thursday.
The effectiveness of protection against the symptomatic form of COVID-19 after the first dose, for unvaccinated persons, was estimated at 53%. AstraZeneki, 54 percent. Pfizer / BioNTech Vaccine.
Overall, the COVID-19 vaccination in England prevented the deaths of 13,000 people by May 9. People over the age of 60, and 39.1 thousand. People over the age of 65 have avoided hospitalization, according to estimates by the British Government Agency for Public Health England (PHE).
“New data confirm the astounding effect of two doses of immunization; the second dose of AstraZeneki gives up to 90 percent.” The British Deputy Minister of Health, Hadeem Al-Zahawi, who was administering the vaccinations, said.
This is the first PHE study to consider the use of two doses of this vaccine.
After the first injection with Pfizer / BioNTechu was observed Slight decrease in vaccine efficacy. This is not noticeable with AstraZeneki, says PHE.
In the United Kingdom, the interval between two doses of vaccines has been extended to 12 weeks, but has recently been reduced to eight weeks for people over the age of 50, according to Reuters reports.
39.1 thousand. People over the age of 65 did not need to be treated for COVID-19 in hospitals.
Fewer Poles are registering for vaccinations. So far, not even half of them have scored
